GREENWICH, Conn. - nvtip -- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet

Experienced, Recognized Orthopedic Business and Surgical Professionals to Help Identify and  Evaluate Strategic Opportunities

Old Greenwich, CT – May 1, 2025 - Mission 3A, a venture studio focused on transforming and scaling breakthrough companies, announced today that its healthcare division, Mission 3A Healthcare, has established a Healthcare Advisory Board and appointed industry leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet.

"We are honored to welcome Patrick, Kevin, and Dr. Berlet to our advisory board. Their collective experience spanning investment, commercialization, and clinical leadership will provide invaluable guidance as we build  and back the next generation of healthcare innovation," said Andy Reid, Partner and COO of Mission 3A's  Healthcare Portfolio. "These appointments bring a powerful combination of clinical insight, commercial  acumen, and strategic guidance to Mission 3A, as we expand our efforts to accelerate high-impact startups at  the intersection of healthcare, AI, and digital health."

More on nvtip.com

• ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
• Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
• Jay Tapp was named Managing Director in British Columbia
• Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
• 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)

"Joining the Mission 3A Healthcare Advisory Board is an exciting opportunity to help shape the future of  MedTech and AI innovation," said Dr. Greg Berlet. "I'm thrilled to contribute my clinical and entrepreneurial  experience to a team that's already making a measurable impact in healthcare."

• Patrick Fisher, President of Global Orthopedics at Orthofix and former executive at Stryker and Wright  Medical, is a commercial leader with deep expertise in orthopedics, biologics, and global strategy.
• Kevin Cordell, has overseen multi-billion dollar orthopedic and cardiovascular businesses, launched  market-leading innovations, and helped deliver significant shareholder value—including the $5.4B  acquisition of Wright Medical by Stryker.
• Greg Berlet, MD, a globally recognized orthopedic surgeon, innovator and educator with extensive experience in clinical leadership and medical education.  Dr. Berlet has authored over 150 peer-reviewed scientific articles and has been instrumental in the design and development of numerous orthopedic implants.

About Mission 3A

More on nvtip.com

• NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
• Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
• DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
• Mix Master AI Bartender Launches Web Platform, Revolutionizing Cocktail Creation
• Evolving Gaming Regulations: New Insights From Info-Tech Research Group Shows How IT Leaders Can Strengthen Compliance and Reduce Risk

Mission 3A is a venture studio dedicated to launching and scaling breakthrough companies. The Mission 3A  Healthcare Portfolio focuses on building and investing in MedTech and Healthcare AI startups that improve  access, affordability, patient outcomes, and operational efficiency. Backed by experienced operators and  investors, the firm partners closely with founders to drive transformative impact through AI, SaaS, and  platform-based solutions.
www.mission3a.com